90 related articles for article (PubMed ID: 2332986)
1. Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness.
Weiss C; Ho AD; Hiller E; Thiel E; Schlag R; Lipp T; Herrmann R; Musch E; Termander B; Hunstein W
Leuk Res; 1990; 14(4):327-32. PubMed ID: 2332986
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptors, clinical characteristics, and implications for prognosis in chronic lymphocytic leukemia.
Simonsson B; Terenius L; Nilsson K
Cancer; 1982 Jun; 49(12):2493-6. PubMed ID: 7074566
[TBL] [Abstract][Full Text] [Related]
3. Does intensive treatment with high dose chlorambucil and prednisone as first line and cladribine as second line influence the survival of the patients with chronic lymphocytic leukemia?
Robak T; Błoński JZ; Kasznicki M
Leuk Lymphoma; 2001 May; 41(5-6):545-57. PubMed ID: 11378572
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells.
Meyers JA; Taverna J; Chaves J; Makkinje A; Lerner A
Clin Cancer Res; 2007 Aug; 13(16):4920-7. PubMed ID: 17699872
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
[TBL] [Abstract][Full Text] [Related]
8. Chlorambucil plus theophylline vs chlorambucil alone as a front line therapy for B-cell chronic lymphatic leukemia.
Mabed M; Aref S; Fouda M; El-Sharawy S
Leuk Lymphoma; 2004 Oct; 45(10):2029-35. PubMed ID: 15370247
[TBL] [Abstract][Full Text] [Related]
9. The UK Medical Research Council CLL trials 1 and 2.
Catovsky D; Fooks J; Richards S
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):423-7. PubMed ID: 3222154
[TBL] [Abstract][Full Text] [Related]
10. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin.
Kermani IA; Dehdilani M; Dolatkhah R
Asian Pac J Cancer Prev; 2007; 8(3):367-71. PubMed ID: 18159969
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
14. [Multidrug resistance in chronic lymphocytic leukemia].
Szendrei T; Magyarlaki T; Kovács G; Nagy A; Szomor A; Molnár L; Dávid M; Tokés-Füzesi M; Rideg O; Pótó L; Pajor L; Kajtár B; Losonczy H
Orv Hetil; 2008 Jan; 149(4):161-7. PubMed ID: 18201958
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid receptors in chronic lymphocytic leukemia.
Levine EG; Peterson BA; Smith KA; Hurd DD; Bloomfield CD
Leuk Res; 1985; 9(8):993-9. PubMed ID: 4046634
[TBL] [Abstract][Full Text] [Related]
16. Therapy program for patients with advanced stages of chronic lymphocytic leukemia. Chlorambucil, splenectomy, and total lymph node irradiation.
Pegourie-Bandelier B; Sotto JJ; Hollard D; Bolla M; Sarrazin R
Cancer; 1995 Jun; 75(12):2853-61. PubMed ID: 7773934
[TBL] [Abstract][Full Text] [Related]
17. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.
Del Principe MI; Dal Bo M; Bittolo T; Buccisano F; Rossi FM; Zucchetto A; Rossi D; Bomben R; Maurillo L; Cefalo M; De Santis G; Venditti A; Gaidano G; Amadori S; de Fabritiis P; Gattei V; Del Poeta G
Haematologica; 2016 Jan; 101(1):77-85. PubMed ID: 26565002
[TBL] [Abstract][Full Text] [Related]
20. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
